PT  - JOURNAL ARTICLE
AU  - Ndié, Justin
AU  - Awono Noah, Jean Pierre Yves
AU  - Ateba Ndongo, Francis
AU  - Fokam, Joseph
AU  - Ketchaji, Alice
AU  - Kana Dongmo, Rogacien
AU  - Bayiha, Christian Noël
AU  - Tchapda, Richard
AU  - Palisson, Tatiana Avang Nkoa
AU  - Bonyohe, Martial Gaël
AU  - Teh Monteh, Caroline
AU  - Wepnyu, Njamsnhi Yembe
AU  - Naah Tabala, Félicité
AU  - Lélé Siaka, Hernandez
AU  - Djofang Yepndo, Carelle
AU  - Djomo Nzaddi, Audrey Raïssa
AU  - Mbella, Maurice Rocher
AU  - Dongmo, Marie Micheline
AU  - Nguemkam, Gildas
AU  - Issouck, Ngo
AU  - Monkam, Nelly
AU  - Madjo Oumbe, Leopoldine
AU  - Moluh, Clifford
AU  - Tjek, Paul
AU  - Colizzi, Vittorio
AU  - Perno, Carlo-Federico
AU  - Cappelli, Giulia
AU  - Ndembi, Nicaise
AU  - Kob, David
AU  - Ekane, Gregory-Edie Halle
AU  - Keugoung, Basile
AU  - Ndjolo, Alexis
AU  - Billong, Serge Clotaire
AU  - Nkenfou, Céline
AU  - Ateudjieu, Jérôme
AU  - Zoung-Kanyi Bissek, Anne Cécile
TI  - Determinants of HIV infection among pregnant women in Cameroon: A contribution toward the elimination of vertical transmission in low- and middle-income countries
AID  - 10.1101/2024.05.15.24307434
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.15.24307434
4099  - http://medrxiv.org/content/early/2024/05/16/2024.05.15.24307434.short
4100  - http://medrxiv.org/content/early/2024/05/16/2024.05.15.24307434.full
AB  - Background The risk of HIV transmission during antenatal care (ANC) in Cameroon remains a concern. According to recent studies, the prevalence of HIV in the country is around 4.5%, which increases the likelihood of vertical transmission.Objective To identify the determinants of HIV infection among pregnant women attending antenatal clinics (ANC) in Cameroon and to estimate HIV seroprevalence.Methods A cross-sectional study was conducted among ANC attendees aged ≥15 years from September 2022 to June 2023 in 324 health facilities in 08 regions of Cameroon (Adamaoua, Yaounde, East, Far-North, Douala, North, West, South). Sociodemographic and clinical data were collected using questionnaire. HIV screening was performed according to the national algorithm. Estimates of HIV seroprevalence and identification of its determinants using multivariable logistic regression (95% CI) were performed with Excel and SPSS 22 software.Results Overall, 10674 pregnant women were enrolled, with median [IQR] age 25 years [21– 30]; 40.0% at a secondary educational level; 44.1% married monogamously; 46.3% multiparous; 38.8% in the second quarter of pregnancy and 16.5% reporting at least one abortion. Overall HIV seroprevalence was 2.6% [95%CI: 2.33; 2.93]. Significantly higher prevalence was found with the regions of Adamaoua (aOR 3.78 [95%CI: 1.87-7.67], p<0.001), East (9.38 [5.6-15.67], p<0.001), North (3.07 [1.74-5.42], p<0.001), South (2.93 [1.66-5.16]; p<0.001); lack of education (2.08 [1.06-4.06], p=0.032), primary education (2.44 [1.32-4.50], p=0.004) and secondary education (2.29 [1.28-4.08], p=0.005) were significantly associated with HIV infection, while monogamous marriage (0.33 [0.22-0.51], p<0.001), the absence of abortion (0.59 [0.37-0.98], p=0.036) and large multiparous (0.38 [0.17-0.82]; p=0.015) were protective.Conclusion Despite the overall low-prevalence among pregnant women at national-level, several factors are associated with HIV in ANC, the absence or low-level of education, being elderly (>30 years), singleness, history of abortion and low parity predicted the HIV status during ANC. Thus, public health interventions towards these at-risk target groups will help to reduce new infections among pregnant women, hence contributing to achieve eMTCT in Cameroon.Competing Interest StatementThe authors have declared no competing interest.Funding StatementElimination of Mother-to-Child Transmission of HIV ProjectAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the National Ethics Committee for Human Health Research (reference number N°2022/08/1478/CE/CNERSH/SP) and an Administrative Research Authorization (reference number N° 631-26-22) was obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data are available